An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder

This publication has 18 references indexed in Scilit:

• Catecholamine mechanisms in age-related cognitive decline
  Neurobiology of Aging, 1993
• Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task
  Psychopharmacology, 1992
• Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype
  Neuropharmacology, 1991
• Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders
  American Journal of Psychiatry, 1991
• Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients
  Psychological Medicine, 1991
• α₂‐Adrenoceptor subtypes and imidazoline‐like binding sites in the rat brain
  British Journal of Pharmacology, 1990
• The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes
  Journal of Neuroscience, 1988
• α ₂ -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman Primates
  Science, 1985
• Factors associated with children’s adherence to stimulant medication.
  Australian and New Zealand Journal of Surgery, 1982
• A Teacher Rating Scale for Use in Drug Studies with Children
  American Journal of Psychiatry, 1969